Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	250-251
Number of pages	2
Journal	Annals of Allergy, Asthma and Immunology
Volume	115
Issue number	3
DOIs	https://doi.org/10.1016/j.anai.2015.06.014
State	Published - 1 Sep 2015
Externally published	Yes

Access to Document

@article{d2c116671afd4f818cebbbab606caf97,

title = "Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis",

author = "Evans, {Martin Oman} and Morris, {Michael J.} and Coop, {Christopher Albert} and Evans, {Sara Ellen}",

year = "2015",

month = sep,

day = "1",

doi = "10.1016/j.anai.2015.06.014",

language = "English",

volume = "115",

pages = "250--251",

journal = "Annals of Allergy, Asthma and Immunology",

issn = "1081-1206",

number = "3",

}

TY - JOUR

T1 - Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis

AU - Evans, Martin Oman

AU - Morris, Michael J.

AU - Coop, Christopher Albert

AU - Evans, Sara Ellen

PY - 2015/9/1

Y1 - 2015/9/1

UR - http://www.scopus.com/inward/record.url?scp=84940726244&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2015.06.014

DO - 10.1016/j.anai.2015.06.014

M3 - Article

C2 - 26162570

AN - SCOPUS:84940726244

SN - 1081-1206

VL - 115

SP - 250

EP - 251

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

IS - 3

ER -